. "4"^^ . "RIV/60162694:G44__/07:00001753!RIV08-MO0-G44_____" . "A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin- and tabun-poisoned rats" . "Srovn\u00E1n\u00ED reaktiva\u010Dn\u00ED \u00FA\u010Dinnosti nov\u011B vyvinut\u00FDch oxim\u016F (K074, K075) a v sou\u010Dasnosti dostupn\u00FDch oxim\u016F (obidoxim, HI-6) na cyklosarinem a tabunem otr\u00E1ven\u00FDch potkanech"@cs . . . "3"^^ . "Due to their reactivating effects, both newly developed K oximes can be considered to be promising oximes for the antidotal treatment of acute tabun poisonings while the oxime HI-6 is still the most promising oxime for the treatment of acute cyclosarin poisonings due to its high potency to reactivate cyclosarin-inhibited acetylcholinesterase in the peripheral as well as central compartment."@en . . "22" . "A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin- and tabun-poisoned rats"@en . . "Kassa, Ji\u0159\u00ED" . "Due to their reactivating effects, both newly developed K oximes can be considered to be promising oximes for the antidotal treatment of acute tabun poisonings while the oxime HI-6 is still the most promising oxime for the treatment of acute cyclosarin poisonings due to its high potency to reactivate cyclosarin-inhibited acetylcholinesterase in the peripheral as well as central compartment." . "Jun, Daniel" . "3"^^ . "297-300" . "D\u00EDky reaktiva\u010Dn\u00EDmu \u00FA\u010Dinku mohou b\u00FDt K oximy pova\u017Eov\u00E1ny za slibn\u00E9 oximy pro antidotn\u00ED terapii akutn\u00ED otravy tabunem, zat\u00EDmco oxim HI-6 je st\u00E1le nejslibn\u011Bj\u0161\u00EDm oximem pro terapii akutn\u00ED atravy cyklosarinem d\u00EDky vysok\u00E9 schopnosti reaktivovat cyklosarinem inhibovanou acetylcholinester\u00E1zu v perifern\u00EDm i centr\u00E1ln\u00EDm komp\u00E1rtmentu."@cs . "3" . . "Srovn\u00E1n\u00ED reaktiva\u010Dn\u00ED \u00FA\u010Dinnosti nov\u011B vyvinut\u00FDch oxim\u016F (K074, K075) a v sou\u010Dasnosti dostupn\u00FDch oxim\u016F (obidoxim, HI-6) na cyklosarinem a tabunem otr\u00E1ven\u00FDch potkanech"@cs . . . . . "407832" . . . "Ku\u010Da, Kamil" . "RIV/60162694:G44__/07:00001753" . . "[6D51B111B503]" . "Z(MO0FVZ0000501)" . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . . . . "A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin- and tabun-poisoned rats" . . . "1475-6366" . . "G44" . "tabun; cyclosarin; acetylcholinesterase; reactivation; oximes; rat; inhibition"@en . . "Journal of Enzyme Inhibition and Medicinal Chemistry" . "A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin- and tabun-poisoned rats"@en .